Rapid diagnostic device for the quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs).
Developing the next generation of rapid diagnostic products to meet the market need for simple to use, rapid, cost effective, portable systems.
We offer a complete integrated solution for the development and manufacturing of lateral flow assays and reader systems.
Need our help with your lateral flow assay growth strategy? https://t.co/Z4zDmKnw35 https://t.co/UjkKdqwhpU
26 May 2017
© Abingdon Health 2017